1-(4-Methylbenzenesulfonyl)-3-[(5-methylthiophen-2-yl)methyl]-3-(pyrazin-2-yl)urea

Catalog No. :
ACBLSF283
CAS No. :
866154-01-0
Molecular Formula :
C18H18N4O3S2
Molecular Weight :
402.50

IUPAC Name:4-methyl-N-(((5-methylthiophen-2-yl)methyl)(pyrazin-2-yl)carbamoyl)benzenesulfonamide

1-(4-Methylbenzenesulfonyl)-3-[(5-methylthiophen-2-yl)methyl]-3-(pyrazin-2-yl)urea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Methylbenzenesulfonyl)-3-[(5-methylthiophen-2-yl)methyl]-3-(pyrazin-2-yl)urea
IUPAC Name4-methyl-N-(((5-methylthiophen-2-yl)methyl)(pyrazin-2-yl)carbamoyl)benzenesulfonamide
MDL No.MFCD00227429
Molecular FormulaC18H18N4O3S2
Molecular Weight402.50
SMILESO=C(N(CC1=CC=C(C)S1)C2=NC=CN=C2)NS(=O)(C3=CC=C(C)C=C3)=O
InChI KeyZQMIFXJSRLSXAT-UHFFFAOYSA-N
Synonym1-(4-methylbenzenesulfonyl)-3-[(5-methylthiophen-2-yl)methyl]-3-(pyrazin-2-yl)urea;Benzenesulfonamide, 4-methyl-N-[[[(5-methyl-2-thienyl)methyl]-2-pyrazinylamino]carbonyl]-
CAS No.866154-01-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACBLSF283 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBLSF283 route product structure diagram
    ACBLSF283866154-01-0
Inquiry

2. ACBLSF283 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBLSF283 route product structure diagram
    ACBLSF283866154-01-0
Inquiry

Comments (0)